Lataa...
Advances in Liver Cancer Antibody Therapies: A Focus on Glypican-3 and Mesothelin
Liver cancer is one of the most common malignancies worldwide. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics. There is an urgent need to identify molecular targets for t...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3198870/ https://ncbi.nlm.nih.gov/pubmed/21942912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11595360-000000000-00000 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|